See All News >
BioPharm Executive: Here's How The Drug Industry Will Finally Hang Itself
Editas Medicine, Juno Therapeutics (JUNO) Hammer Out $727 Million CAR T R&D Deal
Bayer (BAY) Announces Four Strategic Priorities, Restructuring and No Job Cuts
bluebird bio (BLUE) Pads CAR T Arsenal With $131.5 Million Five Prime (FPRX) Pact
Gilead (GILD), GlobeImmune (GBIM)'s Hep B Drug Flunks Phase II Study
Novartis AG (NVS) Partners With Bay Area's Rani Therapeutics on Revolutionary Robotic Pill
Your Analyst-Vetted Guide to the Five Blockbuster Drugs the FDA May Approve This Summer
Amgen (AMGN) Dumps AstraZeneca PLC (AZN) Pact After Patients Developed Suicidal Thoughts
Mylan (MYL) CEO Says Pfizer (PFE) Should Come Calling, As Next Big Deal Speculation Swirls
Advisory Firms Urge Vertex (VRTX) Shareholders to Reject Executive Compensation Package at June 4 Meeting
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each
Betting On Cancer Treatment? Keep An Eye On This Company
Pfizer (PFE) Will Make $120 Billion Bid for GlaxoSmithKline (GSK) in Third Quarter, Says Poll
Another Top Sanofi (SAN.PA) Exec Resigns, As Purging of Old Guard Continues
Ousted Sanofi (SAN.PA) Exec's New Company Aims For $160 Million London IPO
The Most Powerful Women In Science And Health
BioSpace (DHX) Temperature Poll: Will PfizerKline Become the Next Pharma Player?
Novartis AG (NVS) to Show Off New Data on 21 Meds and 11 Investigational Compounds at Major Conferences
See All News >
//-->